Taejoon Pharmaceutical
Organisation
Trials
Collaborator, Phase 4, Completed, 2022, 32 people, 14 Mar 2025, clinicaltrials.gov
Phase 3, Completed, 2014, 158 people, 3 Jun 2015, clinicaltrials.gov
Organisation
Collaborator, Phase 4, Completed, 2022, 32 people, 14 Mar 2025, clinicaltrials.gov
Phase 3, Completed, 2014, 158 people, 3 Jun 2015, clinicaltrials.gov